Astec LifeSciences quarterly results and financials

Astec LifeSciences (ASTEC)₹527.20−7.07%(9 Nov 2026 close)Pesticides & Agrochemicals

Key facts

In the Sep 2026 quarter (consolidated), Astec LifeSciences reported sales of ₹71.91 Cr, down 2.7% from Sep 2025, and net profit of −₹37.15 Cr. For the year to Mar 2026, sales were ₹447 Cr and net profit −₹81.27 Cr.

Sales (Sep 2026): ₹71.91 Cr
Net profit (Sep 2026): −₹37.15 Cr
Sales (FY Mar 2026): ₹447 Cr
Net profit (FY Mar 2026): −₹81.27 Cr
EPS (Sep 2026): ₹−16.81
Borrowings (Mar 2026): ₹450 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Astec LifeSciences quarterly results

₹ crore unless stated; each column is a quarter.

Astec LifeSciences Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	50.92	154	68.88	98.91	93.88	120	90.84	73.89	125	159	83.81	71.91
Expenses	69.13	141	116	118	100	114	102	80.16	121	149	84.20	92.11
Operating Profit	−18.04	13.04	−46.11	−20.05	−6.02	6.02	−11.02	−7.02	4.01	9.03	−1.01	−20.06
OPM %	−36.0%	8.0%	−66.9%	−19.9%	−6.0%	4.6%	−12.0%	−9.0%	3.2%	6.0%	−0.8%	−27.0%
Other Income	0.99	2.01	0.99	2.01	2.01	0.99	0.99	0.99	−0.99	2.99	0.99	0.99
Interest	6.03	7.02	7.03	9.03	10.04	10.04	11.03	8.03	7.02	8.02	8.03	7.03
Depreciation	9.01	9.01	9.01	11.01	11.01	12.01	11.01	10.01	11.01	12.01	11.01	11.02
Profit before tax	−32.05	−1.01	−62.07	−39.03	−25.03	−16.01	−33.04	−24.03	−16.03	−8.01	−19.02	−37.03
Tax %	−24.0%	4.0%	−36.0%	0.0%	61.0%	3.0%	0.0%	0.0%	0.0%	−2.0%	0.0%	0.0%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−1.99	0.00	0.00	0.00
Net Profit	−24.11	−1.01	−40.13	−39.16	−40.15	−16.07	−33.15	−24.11	−16.07	−8.03	−19.06	−37.15
EPS (Rs)	−10.87	−0.44	−17.74	−17.22	−18.04	−7.17	−14.77	−10.97	−7.06	−3.49	−8.41	−16.81

Astec LifeSciences profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Astec LifeSciences Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	232	298	367	430	523	554	676	628	457	380	447	439
Expenses	201	236	299	355	438	444	523	552	465	449	453	447
Operating Profit	32.08	63.19	69.16	76.22	85.21	112	154	77.24	−6.02	−66.19	−4.01	−8.03
OPM %	14.1%	21.1%	19.1%	18.1%	16.1%	20.1%	23.0%	12.1%	−1.3%	−17.0%	−1.0%	−1.8%
Other Income	3.99	−7.99	11.99	10.99	11.99	7.99	9.99	12.98	6.01	5.99	2.99	3.98
Interest	13.05	12.04	11.05	12.05	13.05	5.02	9.04	21.10	25.08	37.13	35.11	30.10
Depreciation	10.01	14.02	15.03	19.02	23.03	26.04	34.03	34.03	36.02	44.02	45.05	45.05
Profit before tax	12.02	29.04	56.04	56.05	61.07	89.09	121	35.04	−62.05	−141	−81.09	−80.09
Tax %	59.0%	33.0%	37.0%	36.0%	23.0%	27.0%	26.0%	27.0%	−24.0%	−4.0%	0.0%	—
Exceptional items	−0.99	−6.99	2.99	0.00	0.00	0.00	0.00	0.00	0.00	1.99	−1.99	−1.99
Net Profit	5.02	19.07	35.15	36.15	48.18	65.24	90.33	26.10	−47.15	−136	−81.27	−80.31
EPS (Rs)	2.25	8.58	15.66	16.04	21.23	29.05	40.15	11.42	−20.96	−60.15	−36.35	−35.77
Dividend payout %	0.0%	15.1%	8.0%	8.0%	6.0%	5.0%	3.0%	12.0%	0.0%	0.0%	0.0%	—

Astec LifeSciences balance sheet

₹ crore, at each year end.

Astec LifeSciences Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	19.05	19.07	20.06	20.08	20.07	20.07	20.07	20.07	20.07	20.08	20.08	22.09
Reserves	116	98.83	119	150	183	226	290	377	400	350	215	368
Borrowings	93.05	127	127	125	176	98.98	187	279	341	495	556	450
Other Liabilities	133	85.41	69.34	120	83.40	227	182	222	220	113	92.44	103
Total Liabilities	362	330	334	413	462	572	679	898	980	976	882	943
Fixed Assets	133	95.18	103	115	167	194	213	341	319	387	500	460
CWIP	12.03	20.04	8.03	42.10	19.04	24.05	116	23.07	127	165	21.05	20.05
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	216	215	223	256	275	354	349	534	534	424	361	463
Inventories	71.72	70.72	65.74	77.69	92.59	121	106	186	294	195	159	137
Trade receivables	104	81.27	111	124	123	161	188	275	156	170	148	249
Cash & equivalents	11.98	5.99	3.99	1.99	0.99	0.99	1.99	1.99	1.99	1.99	2.99	11.98
Total Assets	362	330	334	413	462	572	679	898	980	976	882	943

Astec LifeSciences cash flow

₹ crore, for each year.

Astec LifeSciences Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	6.99	−13.01	18.99	65.04	15.01	168	−7.99	23.98	75.04	10.01	−7.99	−80.98
Cash from investing activity	−18.99	−17.01	−18.02	−49.05	−52.04	−73.99	−73.08	−104	−113	−135	−15.01	−3.99
Cash from financing activity	12.04	31.12	−1.01	−18.07	37.10	−95.26	81.33	80.26	38.12	126	24.10	94.37
Net cash flow	0.00	2.01	1.01	−3.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.03
Capex	20.10	26.02	20.90	49.64	52.76	45.25	102	104	117	135	21.81	5.53
Free cash flow	−13.04	−39.13	−1.01	15.05	−37.10	123	−111	−80.27	−42.14	−125	−24.06	−86.20
CFO / OP %	19.0%	−24.0%	41.0%	115.9%	41.0%	219.0%	13.0%	34.0%	104.0%	−211.0%	20.0%	1,796.0%

Astec LifeSciences ratios

Working-capital days and returns, by year.

Astec LifeSciences Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	142	126	135	122	103	112	123	148	90	135	141	202
Inventory days	148	178	134	123	122	132	114	177	269	225	197	170
Days payable	179	169	116	155	83	218	137	179	161	102	100	107
Cash conversion cycle	109	134	152	89	142	25	100	145	197	256	237	263
Working capital days	20	−27	2	−7	−1	9	5	13	−16	0	−25	−55
ROCE %	20.1%	12.1%	20.0%	22.1%	20.1%	20.1%	22.1%	22.1%	8.1%	−4.0%	−12.9%	−5.0%

Astec LifeSciences: frequently asked questions

What are the latest quarterly results of Astec LifeSciences?

For the Sep 2026 quarter, Astec LifeSciences reported sales of ₹71.91 Cr, down 2.7% year on year and net profit of −₹37.15 Cr. The operating margin was −27.0%.

What is the annual revenue of Astec LifeSciences?

Astec LifeSciences' sales for the year to Mar 2026 were ₹447 Cr; over the last twelve months they were ₹439 Cr.

What is the net profit of Astec LifeSciences?

Net profit for the year to Mar 2026 was −₹81.27 Cr, and −₹80.31 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−35.77.

How much debt does Astec LifeSciences have?

Astec LifeSciences reported borrowings of ₹450 Cr at Mar 2026, against cash and equivalents of ₹11.98 Cr.

What is the free cash flow of Astec LifeSciences?

Cash from operations was −₹80.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹86.20 Cr.

Loading…